Zhengye Biotechnology (NASDAQ:ZYBT) Shares Down 5.8% – What’s Next?

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) fell 5.8% during trading on Tuesday . The company traded as low as $0.7102 and last traded at $0.72. 12,631 shares traded hands during trading, an increase of 16% from the average session volume of 10,898 shares. The stock had previously closed at $0.7647.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Zhengye Biotechnology in a research report on Friday, January 9th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Zhengye Biotechnology has a consensus rating of “Sell”.

Zhengye Biotechnology Price Performance

The company has a quick ratio of 1.10, a current ratio of 1.49 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $0.93 and its 200-day moving average is $2.61.

Hedge Funds Weigh In On Zhengye Biotechnology

Several large investors have recently modified their holdings of ZYBT. XTX Topco Ltd lifted its holdings in Zhengye Biotechnology by 71.4% during the 4th quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock worth $68,000 after purchasing an additional 24,697 shares during the last quarter. WINTON GROUP Ltd lifted its holdings in shares of Zhengye Biotechnology by 193.8% during the fourth quarter. WINTON GROUP Ltd now owns 63,297 shares of the company’s stock worth $73,000 after buying an additional 41,750 shares in the last quarter. Millennium Management LLC bought a new stake in shares of Zhengye Biotechnology in the third quarter valued at about $38,000. Citadel Advisors LLC bought a new stake in shares of Zhengye Biotechnology in the third quarter valued at about $31,000. Finally, Jane Street Group LLC acquired a new position in shares of Zhengye Biotechnology in the second quarter valued at about $1,158,000.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.